CCN1C(NCC(C)C)=N[C@@H](CCc2ccccc2)[C@H](C(=O)NCC(C)C)[C@H]1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?